« Previous
Next »
The Journal of Pain
Volume 12, Issue 11,Supplement
, Pages T92-T101
, November 2011
Potential Genetic Risk Factors for Chronic TMD: Genetic Associations from the OPPERA Case Control Study
| Title | About | Type | File Size |
|---|---|---|---|
| Supplementary Material |
|
0 MB |
Please note that add-on components may require plug-in applications.
Supported by NIH grants U01DE017018, DE016558, P01NS045685, R01DE016155, and F32DE019057, and by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (DZ). The OPPERA program also acknowledges resources specifically provided for this project by the respective host universities: University at Buffalo, University of Florida, University of Maryland-Baltimore, and University of North Carolina-Chapel Hill.
Shad Smith, Roger Fillingim and Gary Slade are consultants and equity stock holders, and William Maixner and Luda Diatchenko are cofounders and equity stock holders in Algynomics, Inc., a company providing research services in personalized pain medication and diagnostics. Portions of these data were presented at the 2010 Annual Scientific Meeting of the American Pain Society in Baltimore, MD.
Supplementary data accompanying this article are available online at jpain.org and sciencedirect.com.
PII: S1526-5900(11)00738-3
doi: 10.1016/j.jpain.2011.08.005
« Previous
Next »
The Journal of Pain
Volume 12, Issue 11,Supplement
, Pages T92-T101
, November 2011
